Applied Therapeutics (APLT) Assets Average (2023 - 2025)
Historic Assets Average for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $35.9 million.
- Applied Therapeutics' Assets Average fell 6939.71% to $35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year decrease of 6939.71%. This contributed to the annual value of $70.8 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Applied Therapeutics' Assets Average is $35.9 million, which was down 6939.71% from $47.1 million recorded in Q2 2025.
- Applied Therapeutics' Assets Average's 5-year high stood at $139.5 million during Q2 2024, with a 5-year trough of $35.9 million in Q3 2025.
- For the 3-year period, Applied Therapeutics' Assets Average averaged around $74.2 million, with its median value being $60.9 million (2023).
- Its Assets Average has fluctuated over the past 5 years, first soared by 27883.5% in 2024, then plummeted by 6939.71% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Assets Average stood at $50.0 million in 2023, then surged by 93.2% to $96.6 million in 2024, then crashed by 62.89% to $35.9 million in 2025.
- Its Assets Average stands at $35.9 million for Q3 2025, versus $47.1 million for Q2 2025 and $71.8 million for Q1 2025.